comparemela.com
Home
Live Updates
Maryn Walsh - Breaking News
Pages:
2
3
4
5
6
7
8
Maryn Walsh News Today : Breaking News, Live Updates & Top Stories | Vimarsana
No Net HF Benefit for Interarterial Shunt Device
For an all-comer population with any impairment of LV function, an interarterial shunt device missed the primary endpoint in RELIEVE-HF, but benefit was seen with LVEF less than 40%.
United states
New york
Maryn walsh
Patrickt ogara
Icahn school of medicine at mount sinai
American college of cardiology
Right chamber overload might explain harm
Icahn school
Mount sinai
American college
Scientific session
V wave ltd
Vincent hospital
Heart failure
Rejection fraction
F ejection fraction
HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show
Fewer Black patients underwent transplant by 1 year, but for those who got a heart, outcomes didn’t differ by gender or race.
United states
Los angeles
Rebeccas steinberg
Maryn walsh
Jaime moriguchi
Medtronic heartware
Md emory university
Drug administration
Vincent heart center
Transplantation network
Abbott cardiovascular
Emory university
Heart failure
Organ procurement
Cedars sinai hospital
African americans
Two Evidence-Based Pathways for Stable Angina: ORBITA-2 Editorial
The trial made several “Best of 2023” lists, but how it will alter clinical practice in the coming years is uncertain.
United states
United kingdom
Stoke on trent
Harvey white
Davidj cohen
Maryn walsh
Sanjit jolly
Vincent heart center
American heart association
Dphil keele university
Health new zealand auckland city hospital
Md mcmaster university population health research institute
Health new
Auckland city hospital
New england journal
Top coronary artery disease news
TCTMD s Top 10 Most Popular Stories for September 2023
The most-read articles on TCTMD this month spanned the breadth of cardiology research and care.
Maryn walsh
Matthew budoff
Michelle kittleson
Drugs chosen
Medicare negotiations hit close
Birth control
Together linked
Professional opportunities
Let your priorities be
Nonculprit lesions tied
First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists
Optimism must be balanced with conservative expectations given the unknown nature of the cost impact, says Mary N. Walsh.
White house
District of columbia
United states
Boehringer ingelheim eli lilly
Bayer janssen
Maryn walsh
Bristol myers squibb
Abbvie johnson
American college of cardiology
Novo nordisk
Vincent heart center
Inflation reduction act
Eli lilly
American college
vimarsana © 2020. All Rights Reserved.